A number of NZMCC projects are getting underway as the industry prepares for amendments to the Misuse of Drugs Act and the development of associated regulations.
NZMCC is working on a project to assess the clinical safety evidence for CBD products and another initiative focused on increasing prescriber and pharmacist training options.
We will be working with standards-setting bodies and regulators on a number of industry areas to establish robust standards for industry activities including:
- testing of cannabinoids in plants and products;
- cultivation and harvesting of cannabis for medicinal purposes;
- extraction and processing methods;
- labelling and advertising of medicinal cannabis products.
We are also discussing with Medical Cannabis Awareness New Zealand a set of proposed guidelines for colour-coding products sold in New Zealand based on their ratio of THC:CBD.